To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.

Summary

Full Text

Legislative Actions

1. 2021-06-30

   Introduced in House

2. 2021-06-30

   Introduced in House

3. 2021-06-30

   Referred to the House Committee on Energy and Commerce.

4. 2021-07-01

   Referred to the Subcommittee on Health.